The impact of long-term azithromycin on antibiotic resistance in HIV-associated chronic lung disease

Regina E. Abotsi, Mark P. Nicol, Grace McHugh, Victoria Simms, Andrea M. Rehman, Charmaine Barthus, Lucky G. Ngwira, Brenda Kwambana-Adams, Robert S. Heyderman, Jon Ø. Odland, Rashida A. Ferrand, Felix S. Dube

Source: ERJ Open Res, 8 (1) 00491-2021; 10.1183/23120541.00491-2021
Journal Issue: January

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Regina E. Abotsi, Mark P. Nicol, Grace McHugh, Victoria Simms, Andrea M. Rehman, Charmaine Barthus, Lucky G. Ngwira, Brenda Kwambana-Adams, Robert S. Heyderman, Jon Ø. Odland, Rashida A. Ferrand, Felix S. Dube. The impact of long-term azithromycin on antibiotic resistance in HIV-associated chronic lung disease. ERJ Open Res, 8 (1) 00491-2021; 10.1183/23120541.00491-2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Why short-term antibiotic use in AECB may influence long-term outcomes
Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI
Year: 2005

Long-term macrolide treatment for chronic respiratory disease
Source: Eur Respir J 2013; 42: 239-251
Year: 2013



The effect of long-term macrolides therapy for acute exacerbation of chronic obstructive pulmonary disease: A meta-analysis
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012

Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD
Source: Eur Respir J 2009; 33: 282-288
Year: 2009



Azithromycin, a novel maintenance therapy in patients with chronic non-CF suppurative lung disease
Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Year: 2011

Efficacy of azithromycin vs. ciprofloxacin in the treatment of patients with acute bacterial exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 544s
Year: 2002

Antibiotic treatment and prophylaxis
Source: Annual Congress 2006 - Infections and chronic obstructive lung diseases
Year: 2006


Bacteria, antibiotics and COPD
Source: Eur Respir J 2001; 17: 995-1007
Year: 2001



Comparison of the efficacy of azythromycin and roxithromycin in the treatment of acute purulent exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 138s
Year: 2001

Efficacy of low-dose, long-term clarithromycin administration in improving the clinical course in cystic fibrosis patients with chronic P. aeruginosa airway colonization
Source: Eur Respir J 2003; 22: Suppl. 45, 514s
Year: 2003

The clinical impact of adherence to therapy in airways disease
Source: Breathe, 17 (2) e017902; 10.1183/20734735.0039-2021
Year: 2021



What is the role of prophylactic antibiotic therapy in chronic bronchitis or COPD?
Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new?
Year: 2009



Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD
Source: Eur Respir J 2009; 34: 1066-1071
Year: 2009



Evaluation of tuberculosis risk in patients submitted to chronic immunosuppressive therapy for osteoarticular immune disease
Source: Eur Respir J 2006; 28: Suppl. 50, 131s
Year: 2006

Effect of azithromycin treatment on inflammation in COPD patients
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019


Acute exacerbation of bronchiectasis and the impact on the duration of antibiotic therapy
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019


The efficacy and treatment length of oral corticosteroids in patient with acute exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 295s
Year: 2005

Effect of long-term treatment with fenspiride on clinical and functional status of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: management
Year: 2010


Perspectives on antibiotic treatment of NTM pulmonary disease
Source: Eur Respir Monogr 2017; 75: 245-252
Year: 2017


Long-term benefits of antibiotic treatment in reducing recurrence rates and resource utilization in acute exacerbations of chronic bronchitis (AECB)
Source: Annual Congress 2003 - Outcome of acute exacerbations in COPD
Year: 2003